Colorectal Cancer Markers: Discovering Region-S...

By HEOR Staff Writer

October 15, 2025

Colorectal cancer markers like NOX1 and NPY1R are changing the way experts diagnose and manage colon cancer. But how do these region-specific markers impact colorectal cancer detection, prognosis, and personalized therapies? Recent breakthroughs s...
Tukysa Breast Cancer Therapy Boosts Progression-Free Survival in Advanced Cases
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...
Lurbinectedin SCLC Therapy: FDA Approval and Its Economic Implications
Enhertu Breast Cancer Treatment: Major Advances in Invasive Disease-Free Surv...
Transforming Cancer Treatment: Implications of Subcutaneous Pembrolizumab App...
NIVOPOSTOP Trial Results: A Landmark Breakthrough in Head and Neck Cancer Tre...
NICE Kidney Cancer Guideline: Enhancing Biopsy Use to Minimize Unnecessary Su...
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival
FDA Guidance on Overall Survival Assessment in Oncology Trials
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
PADCEV KEYTRUDA Urothelial Cancer: Advancements in Survival Outcomes and Econ...